Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

8279 SYNGEN

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Chen, Wei-Jen

Jesse Wu

(06)6323588

Building A, NO.154,Kai-Yuan Road,Hsin-Ying(730), Tainan, Taiwan

2016/09/26

Industry

Main Business

Biotechnology and Medical Care

SYNGEN BIOTECH Founded in April 1999, Syngen Biotech Co., Ltd is a fast-growing biotech company which specialized in strain identification, micro-organism fermentation, recovery and purification to improve people’s lives by providing the best quality of products such as active pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products. We strive to become a top tier global active pharmaceutical ingredient (APIs) manufacturer and an excellent supplier of dietary supplement in Taiwan.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2023/06/02 )
18.452	184.50	181.50	184.00	0.50	28		N/A	N/A
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2023/06/02)	TPEx measures adopted (2023/06/02)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	N	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile